Harnessing the immune system: Insights into cancer vaccines
Advances in Immunology · 2025
DOI: 10.1016/bs.ai.2024.10.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Immunology, 2025. Verfasst von Sushree Subhadra Acharya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT) Deemed to be University (Institute of Eminence), …. Hauptthemen laut MEDLINE: Cancer Vaccines, Neoplasms, Immune System, Immunotherapy. Die Arbeit nennt 75 Literaturangaben.
Abstract (Originalsprache)
Cancer vaccines have become a promising approach in the fight against cancer, harnessing the remarkable capability of the human immune system to recognize and eliminate cancer cells. These vaccines are specifically engineered to activate the immune response against malignant cells, marking a significant advancement in contemporary research. By capitalizing on the unique ability of the immune system to detect and eliminate cancer cells, these vaccines present promising prospects for both prevention and therapeutic intervention. Recent advancements have provided profound insights into how these vaccines can be tailored to target specific cancer types, enhancing their efficacy and minimizing side effects. This innovative strategy holds the potential to transform cancer care, offering new avenues for durable and effective treatments. This chapter delves into the historical context of cancer vaccine research, discussing various types of cancer vaccines, their mechanisms of action, and the role of adjuvants and delivery systems in enhancing vaccine efficacy. It also covers tumor immunogenicity, how tumor cells evade the immune system, and the combined use of cancer vaccines with other treatment approaches. The chapter aims to elucidate the potential of cancer vaccines to revolutionize cancer treatment and improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT) Deemed to be University (Institute of Eminence), Campus-11, Patia, Bhubaneswar, Odisha, India.
- Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT) Deemed to be University (Institute of Eminence), Campus-11, Patia, Bhubaneswar, Odisha, India; Department of Molecular,…
- Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT) Deemed to be University (Institute of Eminence), Campus-11, Patia, Bhubaneswar, Odisha, India. Electronic address: cnku…
Zitieren
APA
Acharya, S. S., Bhal, S., Das, B., & Kundu, C. N. (2025). Harnessing the immune system: Insights into cancer vaccines. Advances in Immunology. https://doi.org/10.1016/bs.ai.2024.10.006
Vancouver
Acharya SS, Bhal S, Das B, Kundu CN. Harnessing the immune system: Insights into cancer vaccines. Advances in Immunology. 2025. doi:10.1016/bs.ai.2024.10.006
BibTeX
@article{Acharya2025,
author = {Acharya, Sushree Subhadra and Bhal, Subhasmita and Das, Biswajit and Kundu, Chanakya Nath},
title = {Harnessing the immune system: Insights into cancer vaccines},
journal = {Advances in Immunology},
year = {2025},
doi = {10.1016/bs.ai.2024.10.006}
}
EUVIMED